|
1
|
Li G, Zhou CL, Zhou QS and Zou HD:
Galantamine protects against lipopolysaccharide-induced acute lung
injury in rats. Braz J Med Biol Res. 49(e5008)2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Do-Umehara HC, Chen C, Urich D, Zhou L,
Qiu J, Jang S, Zander A, Baker MA, Eilers M, Sporn PH, et al:
Suppression of inflammation and acute lung injury by Miz1 via
repression of C/EBP-δ. Nat Immunol. 14:461–469. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Tauseef M, Knezevic N, Chava KR, Smith M,
Sukriti S, Gianaris N, Obukhov AG, Vogel SM, Schraufnagel DE,
Dietrich A, et al: TLR4 activation of TRPC6-dependent calcium
signaling mediates endotoxin-induced lung vascular permeability and
inflammation. J Exp Med. 209:1953–1968. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
He Z, Chen X, Wang S and Zou Z: Toll-like
receptor 4 monoclonal antibody attenuates
lipopolysaccharide-induced acute lung injury in mice. Exp Ther Med.
8:871–876. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Deng Y, Yang Z, Gao Y, Xu H, Zheng B,
Jiang M, Xu J, He Z and Wang X: Toll-like receptor 4 mediates acute
lung injury induced by high mobility group box-1. PloS One.
8(e64375)2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang M, Zou L, Feng Y, Chen YJ, Zhou Q,
Ichinose F and Chao W: Toll-like receptor 4 is essential to
preserving cardiac function and survival in low-grade polymicrobial
sepsis. Anesthesiology. 121:1270–1280. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ju M, Liu B, He H, Gu Z, Liu Y, Su Y, Zhu
D, Cang J and Luo Z: MicroRNA-27a alleviates LPS-induced acute lung
injury in mice via inhibiting inflammation and apoptosis through
modulating TLR4/MyD88/NF-κB pathway. Cell Cycle. 17:2001–2018.
2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hu N, Wang C, Dai X, Zhou M, Gong L, Yu L,
Peng C and Li Y: Phillygenin inhibits LPS-induced activation and
inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway. J
Ethnopharmacol. 248(112361)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cao C, Yin C, Shou S, Wang J, Yu L, Li X
and Chai Y: Ulinastatin protects against LPS-induced acute lung
injury by attenuating TLR4/NF-κB pathway activation and reducing
inflammatory mediators. Shock. 50:595–605. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854.
1993.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wightman B, Ha I and Ruvkun G:
Posttranscriptional regulation of the heterochronic gene lin-14 by
lin-4 mediates temporal pattern formation in C. elegans. Cell.
75:855–862. 1993.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lytle JR, Yario TA and Steitz JA: Target
mRNAs are repressed as efficiently by microRNA-binding sites in the
5' UTR as in the 3' UTR. Proc Natl Acad Sci USA. 104:9667–9672.
2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Fujiwara T and Sakamoto H: RNA binding
proteins play the leading part of posttranscriptional regulation of
gene expression in nerve. Tanpakushitsu Kakusan Koso. 51:2609–2616.
2006.PubMed/NCBI(In Japanese).
|
|
14
|
Sonkoly E, Stahle M and Pivarcsi A:
MicroRNAs and immunity: Novel players in the regulation of normal
immune function and inflammation. Semin Cancer Biol. 18:131–140.
2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Sheedy FJ and O'Neill LA: Adding fuel to
fire: MicroRNAs as a new class of mediators of inflammation. Ann
Rheum Dis. 67 (Suppl 3):i50–i55. 2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Mirjam P, Ken R, Irene H and Tania M:
miR-223: A key regulator in the innate immune response in asthma
and COPD. Front Med (Lausanne). 19(196)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Dorhoi A, Iannaccone M, Farinacci M, Faé
KC, Schreiber J, Moura-Alves P, Nouailles G, Mollenkopf HJ,
Oberbeck-Müller D, Jörg S, et al: MicroRNA-223 controls
susceptibility to tuberculosis by regulating lung neutrophil
recruitment. J Clin Invest. 123:4836–4848. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Feng Z, Qi S, Zhang Y, Qi Z, Yan L, Zhou
J, He F, Li Q, Yang Y, Chen Q, et al: Ly6G+ neutrophil-derived
miR-223 inhibits the NLRP3 inflammasome in mitochondrial
DAMP-induced acute lung injury. Cell Death Dis.
8(e3170)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mogensen TH: Pathogen recognition and
inflammatory signaling in innate immune defenses. Clin Microbiol
Rev. 22:240–273. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ulloa L, Brunner M, Ramos L and Deitch EA:
Scientific and clinical challenges in sepsis. Curr Pharm Des.
15:1918–1935. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mathers CD and Loncar D: Projections of
global mortality and burden of disease from 2002 to 2030. PloS Med.
3(e442)2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mamishi S, Mahmoudi S, Naserzadeh N,
Hosseinpour SR, Haghi AM, Bahador A, Abdosalehi MR, Rahmani M and
Pourakbari B: Antibiotic resistance and genotyping of gram-negative
bacteria causing hospital-acquired infection in patients referred
to children's medical center. Infect Drug Resist. 12:3377–3384.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Si-Tahar M, Touqui L and Chignard M:
Innate immunity and inflammation-two facets of the same
anti-infectious reaction. Clin Exp Immunol. 156:194–198.
2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ramkissoon SH, Mainwaring LA, Ogasawara Y,
Keyvanfar K, McCoy JP Jr, Sloand EM, Kajigaya S and Young NS:
Hematopoietic-specific microRNA expression in human cells. Leuk
Res. 30:643–647. 2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Neudecker V, Haneklaus M, Jensen O,
Khailova L, Masterson JC, Tye H, Biette K, Jedlicka P, Brodsky KS,
Gerich ME, et al: Myeloid-derived miR-223 regulates intestinal
inflammation via repression of the NLRP3 inflammasome. J Exp Med.
214:1737–1752. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nishimoto N and Kishimoto T: Interleukin
6: From bench to bedside. Nat Clin Pract Rheumatol. 2:619–626.
2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Heinrich PC, Behrmann I, Haan S, Hermanns
HM, Müller-Newen G and Schaper F: Principles of interleukin
(IL)-6-type cytokine signalling and its regulation. Biochem J.
374:1–20. 2003.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Naugler WE and Karin M: The wolf in
sheep's clothing: The role of interleukin-6 in immunity,
inflammation and cancer. Trends Mol Med. 14:109–119.
2008.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Takeuchi O and Akira S: Pattern
recognition receptors and inflammation. Cell. 140:805–820.
2010.PubMed/NCBI View Article : Google Scholar
|
